Close Menu

Breaking News

Quantitative Medicine has developed a computational drug discovery platform, called Core, that can predict the main effects of drugs on disease-associated targets.

News items for the week of Jan. 20, 2020.

A federal judge granted IonPath's motion to dismiss portions of Fluidigm's suit but claims of direct infringement were untouched and will proceed.

Researchers from UBC, the BC Centre for Disease Control, and elsewhere will conduct a multi-omics study of the foodborne pathogen.

The panels will select candidate genes that will have a high impact on clinical practice in areas of high priority for participating institutes and centers.

The company, which is developing an assay for the 2019-nCoV coronavirus, is offering about 3.5 million shares of its common stock at $1.45 per share.

The Seattle-based immune sequencing firm will not receive any proceeds from the sale of the shares.

The layoffs occurred across 23andMe's consumer business, which is being restructured, but did not impact its therapeutics business.

QCMD said it will use the technology to develop new reagents for use with its own molecular infectious disease proficiency testing solutions.

Exome sequences for nearly 35,600 cases and controls revealed genes prone to mutation in autism spectrum disorder, along with related cell types, functions, and developmental stages.

The Medical Genome Reference Bank, which currently holds data for more than 2,500 healthy elderly Australians, could help scientists understand the genetics of healthy aging.

The deal comes on the heels of a colorectal cancer-focused drug-discovery alliance that the German companies formed in early 2019.

Myriad filed an sPMA for myChoice CDx despite GSK's confidence that Zejula will be approved in newly diagnosed ovarian cancer regardless of biomarker status.

10x Genomics sued Harvard University and 1CellBio, a competing single-cell technology firm, in 2018 over licenses for patents granted to both companies.

The Komen Tissue Bank will use LifeOmic's Precision Health Cloud platform for genomic, clinical, and imaging data aggregation and analysis, among other things.

The genomes of four children who died in Cameroon 3,000 to 8,000 years ago pointed to diverse early lineages and helped tease out historical population relationships.

The reagent is used for the detection of cytokeratin 19 mRNA in surgically removed sentinel lymph nodes in order to diagnose lymph node metastasis.

The companies are looking to model gene expression signatures to predict treatments for gastric cancer and improve patient stratification methodologies. 

Abbott said the increase in diagnostics revenue was driven by adoption of the company's Alinity family of diagnostic instruments.

The partners will extend the lung cancer biomarker study to countries in and outside Europe, and see if liquid biopsy could offer benefits to tissue-based testing.

The devices are used for collection and stabilization of saliva samples for genetic testing, such as diagnostic testing or direct-to-consumer use.

Blood and skin cell transcriptomes revealed a JAK-STAT signaling and human herpesvirus targets in an individual with refractory drug-induced hypersensitivity syndrome.

The company recently changed its name from Expedeon following the sale of its immunology and proteomics businesses to Abcam.

Pages

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.